Symbols

PPCB

Propanc Biopharma·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About PPCB

Propanc Biopharma, Inc.

Australian Clinical Stage Cancer Therapy Company

Industry

Pharmaceutical

Established Date

10/15/2007

Listing Date

08/15/2025

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

06-30

Website

www.propanc.com

Security Type

Common stock

Office address

302, 6 Butler Street, Camberwell, VIC Australia 3124

Business

Introduction

Propanc Biopharma, Inc., was originally established on October 15, 2007 in Melbourne, Victoria, Australia. On November 23, 2010, the company was re-registered and re-registered in Delaware. They are a development-stage healthcare company currently focused on developing new cancer treatments for patients with pancreatic, ovarian and cancer. Using their scientific and oncology advisors, they developed a rational compounded formulation of anti-cancer compounds that work together in a variety of ways to control or prevent tumor recurrence and spread in the body. Their main product candidate, PRP, is a variant of their new formulation involving zymogen, the inactive precursor of the enzyme.